Autonomix Medical Inc(AMIX) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
September 11 at 4:10 PM ET (Korea 9/12 05:10)
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -46.48 | Insider Own | 2.62% | Shs Outstand | 1.8M | Perf Week | -6.62% |
| Market Cap | 0.01B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 1.8M | Perf Month | -42% |
| Enterprise Value | 0.00B | PEG | - | EPS next Q | - | Inst Own | 2.78% | Short Float | 3.29% | Perf Quarter | -46.51% |
| Income | -0.02B | P/S | - | EPS this Y | - | Inst Trans | 5.8% | Short Ratio | 0.01 | Perf Half Y | -50.69% |
| Sales | 0.00B | P/B | 0.75 | EPS next 5Y | - | ROA | -248.22% | Short Interest | 0.06M | Perf YTD | -62.16% |
| Book/sh | 5.83 | P/C | 2.31 | EPS past 3/5Y | -3.02% 35.84% | ROE | -315.99% | 52W High | -86.57% ($32.55) | Perf Year | -82.06% |
| Cash/sh | 1.89 | P/FCF | - | Sales past 3/5Y | - | ROIC | -509.36% | 52W Low | 79.1% ($2.44) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 64.78% | Gross Margin | - | Volatility(W/M) | 6.73% 12.36% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 1.02 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 4.85 | EPS Q/Q | 77.77% | Profit Margin | - | RSI (14) | 41.9 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 4.85 | Sales Q/Q | - | SMA20 | -18.32% ($5.35) | Beta | -1 | Target Price | $58.8 |
| Payout | - | Debt/Eq | 0 | Earnings | 2026/09/02 | SMA50 | -26.68% ($5.96) | Rel Volume | 0.01 | Prev Close | $4.39 |
| Employees | - | LT Debt/Eq | 0 | EPS/Sales Surpr. | - | SMA200 | -50.22% ($8.78) | Avg Volume(3M) | 4.51M | Price | $4.37 |
| IPO | 2024/1/29 | Option/Short | No/Yes | Trades | 532 | Volume | 52,289 | Change | -0.34% |
Company
AMIX is a Healthcare sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
🩺 A US micro-cap clinical-stage medical device company developing catheter-based nerve sensing and blocking technology. Using microchip sensing array antennas to precisely measure nerve signals, the company aims to apply this technology to nerve-related treatments, such as pain relief for pancreatic cancer patients.
Over the past 1 year, on the lower side
87% below its 1-year high.
AMIX has weak earning power
Losses or thin margins. Early-stage growth or weakening competitiveness
Tap to view numbers
The price looks about right
Trading at - times earnings.
Tap to view numbers
Results came in about as expected
Generally in line with estimates
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have lost money
Tap to view numbers
Dividends are hard to expect
This stock does not pay dividends
Ownership looks stable
Institutions hold 2.8%.
Tap to view numbers
It ranks #4 in the industry
Based on market cap of $8M.
AMIX $8M PER -
ABT $176B PER 33.0
MDT $116B PER 22.4
SYK $106B PER 28.6
FAQ
What kind of company is AMIX?
AMIX belongs to the Healthcare sector and operates in the Medical Devices industry.
What is the market cap of AMIX?
The market cap of AMIX is approximately $8M, ranking 5,575 within its sector.
What is the 52-week high and low for AMIX?
AMIX has recorded a 52-week high of $32.55 and a low of $2.44.
